Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EHMT2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
mRNA | KAT6A | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
mRNA | ZBTB12 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | CTD-2583A14.9 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-08 |
mRNA | PRR12 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |